. "Duployez N, Largeaud L, Duchmann M, et al. Prognostic impact of <i>DDX41</i> germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study. <i>Blood</i>. 2022;140(7):756-768.." Blood, 2025. doi:10.1182/blood.2025029967